Transjugular intrahepatic portosystemic shunt does not independently increase risk of death in high model for end stage liver disease patients.
about
Transjugular intrahepatic portosystemic shunt does not independently increase risk of death in high model for end stage liver disease patients.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Transjugular intrahepatic port ...... stage liver disease patients.
@en
Transjugular intrahepatic port ...... stage liver disease patients.
@nl
type
label
Transjugular intrahepatic port ...... stage liver disease patients.
@en
Transjugular intrahepatic port ...... stage liver disease patients.
@nl
prefLabel
Transjugular intrahepatic port ...... stage liver disease patients.
@en
Transjugular intrahepatic port ...... stage liver disease patients.
@nl
P2093
P2860
P356
P1476
Transjugular intrahepatic port ...... d stage liver disease patients
@en
P2093
Erin K Spengler
Lawrence G Hunsicker
M Bridget Zimmerman
Michael D Voigt
P2860
P304
P356
10.1002/HEP4.1053
P50
P577
2017-06-07T00:00:00Z